JPRN-UMIN000014355
Completed
未知
ncontrolled trial of Rituximab treatment on refractory or steroid dependent nephrotic syndrome in adult. - Uncontrolled trial of Rituximab treatment on refractory or steroid dependent nephrotic syndrome in adult.
Saitama Medical University Department of Nephrology0 sites5 target enrollmentJuly 1, 2014
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- refractory or steroid dependent nephrotic syndrome
- Sponsor
- Saitama Medical University Department of Nephrology
- Enrollment
- 5
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Positive serology for hepatitis B, Cardiac failure, Lung dysfunction, Bone marrow dysfunction, Pregnant subjects or subjects who do not agree with contraception during the study period
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Not Applicable
A Randomized Controlled Trial of Rituximab Versus Steroids and Cyclophosphamide in the Treatment of Idiopathic Membranous Nephropathy (IMN)MN is an autoimmune disease, suggesting that the disease may be triggered by isotype specific autoantibodies directed against podocyte enzymes and podocyte receptors that are recognized as antigens. The key role of IgG antibodies formation in the pathogenesis of IMN suggests that B cell depletion may favourably impact the evolution of the glomerular disease and reduce proteinuria. We propose this study in order to test in a randomized controlled trial the hypMedDRA version: 14.1Level: PTClassification code 10018372Term: Glomerulonephritis membranousSystem Organ Class: 10038359 - Renal and urinary disordersTherapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Therapeutic techniques [E02]EUCTR2011-006115-59-ITAZIENDA OSPEDALIERA SPEDALI CIVILI DI BRESCIA
Active, not recruiting
Not Applicable
Pilot study to evaluate the effect of Rituximab in combination with MTX in the inhibition of progression of synovitis, bone marrow edema, and erosions evaluated by magnetic resonance imaging (MRI) in the hand of patients with rheumatoid arthritis. - NDRheumatoid arthritisMedDRA version: 9.1Level: LLTClassification code 10039073Term: Rheumatoid arthritisEUCTR2007-001754-11-ITROCHE
Active, not recruiting
Not Applicable
A randomized trial of Rituximab in induction therapy for living donor renal transplantation - Randomized trial of rituximab in renal transplantatioEnd stage renal diseaserenal function after renal transplantationMedDRA version: 17.0Level: PTClassification code 10038533Term: Renal transplantSystem Organ Class: 10042613 - Surgical and medical proceduresTherapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Diagnosis [E01]EUCTR2009-017066-23-GBGuys and St Thomas Foundation Trust
Active, not recruiting
Phase 1
A multi-centre pilot study of Rituximab in patients with active PsAEUCTR2006-000844-17-SKVienna Medical University30
Recruiting
Not Applicable
Clinical trial of Rituximab for desensitization or antibody mediated rejection therapy in anti-donor HLA antibody positive patientsChronic renal dysfunction or post kidney transplant recipientsJPRN-jRCTs031180323Saito Kazuhide20